Smithers Pharmaceutical Development Services staff members have over 10 years of experience in bioanalytical analysis of biosimilar development. Using multiple immunoassay platforms and bio-/cell-based assays Smithers has the scientific and regulatory expertise in bioequivalence evaluation within the most stringent timeframes. Services include PK, ADA, Nab and fit-for-purpose biomarker assays.

Latest Resources

See all resources